A Study of Sativex® for Relief of Spasticity in Subjects With Multiple Sclerosis.

Status:
Completed

Trial end date:
2004-03-01

Target enrollment:

Participant gender:

The purpose of this study is to evaluate the efficacy, safety and tolerability of Sativex® in subjects diagnosed with MS and spasticity.

Phase 3

GW Pharmaceuticals Ltd.

Nabiximols